Health & Longevity — Targeting System

Founder kicked off 2026-05-06 (iMessage). Goal: manage health the same way RDCO runs bets — sensors, actions, outcome target, feedback loop.

The four-layer model, applied to Ben’s body

The founder’s framing was correct on first try. The targeting-system structure transfers directly:

Outcome target — the load-bearing decision

Founder is right that “still alive” is too low a bar. Three candidate targets, ranked by RDCO-fit:

Candidate A — Centenarian Decathlon (Attia’s framework)

Define 10 specific physical capabilities Ben wants to retain at age 80 (“the marginal decade”). Backsolve to today’s training prescription.

• Examples of Decathlon events: carry 50 lb up 4 flights, dead-hang 60s, deadlift 0.5×bodyweight, get up off the floor without using hands, hike a 10° grade for 60min carrying a backpack, sprint to catch a grandkid for 30s, jump rope 60s.
• Why it fits: concrete, measurable, non-arbitrary, biases the optimization toward functional strength + VO2max + grip + balance instead of bloodwork-only optics.
• Operational target today: keep VO2max in the top decile for age, deadlift 1.5-2× bodyweight, plate-walk carries >50 lb, Zone 2 base of 4×45min/wk.
• See: 2026-05-06-attia-longevity-framework.md (synthesis filed today)

Candidate B — Top-decile biomarker percentile

Get every key biomarker into the top decile for Ben’s age cohort. Optimize for the worst-positioned one each cycle.

• Sensors: comprehensive bloodwork (Function Health $499/yr, or single Inside Tracker panel ~$300), DEXA scan annually ($150), VO2max test, ApoB + Lp(a) (Attia’s two non-negotiables), HbA1c, hsCRP, full thyroid + sex hormones.
• Why it fits: highly RDCO-style — a single composite metric you can graph month-over-month.
• Risk: biomarker chasing without functional capability follow-through is a trap (Goodhart’s law on biomarkers — easy to gamify, e.g. starve yourself thin and HbA1c looks great while VO2max collapses).

Candidate C — Composite (HealthSpan + biomarker percentile + decathlon)

The hybrid. Track all three but designate one as the binding constraint each quarter.

• How it works: every quarterly review, identify the worst-positioned of the three; the next quarter’s actions optimize for that.
• Why it fits RDCO best: mirrors how /self-review identifies the binding constraint each cycle and how /improve picks the lowest-hanging fix. Same loop, biological substrate.
• Most defensible — no single dimension can drift unmonitored.

Recommendation: Candidate C. Quarterly rotation. Default this quarter = bloodwork baseline + Whoop sensor wiring (because we have zero quantitative starting point right now).

Sensor inventory + acquisition plan

Already owned

• ✅ Whoop (HRV, sleep stages, RHR, recovery score, strain, blood-pressure if 4.0). Has an API. Highest-cadence sensor we have.
• ✅ Apple Health (steps, weight if synced, mindfulness, possibly some Whoop crossover). Founder gave the Claude iOS app access — useful for that surface but does NOT carry to Claude Code.

Recommended adds (priority order)

1. Annual physical with a Med 3.0-aware doctor — request the Attia bloodwork panel: ApoB, Lp(a), full lipid (not just LDL/HDL), hsCRP, fasting insulin, HbA1c, full thyroid (TSH + T3 + T4 + reverse T3), sex hormones (testosterone + free T + SHBG + estradiol + DHEA-S), homocysteine, vitamin D, B12. Cost: covered by insurance if you ask for it; ~$300-500 out of pocket if not. (Bloodwork-first before any supplement protocol.)
2. DEXA scan — body composition + bone density baseline. ~$150 one-time, ~$150 annual. Tampa has multiple BodySpec / DexaFit shops.
3. VO2max test — gold standard is a treadmill ergometer test at a sports-medicine clinic ($150-300). Whoop estimates VO2max but the estimate is noisy.
4. Function Health ($499/yr) or Inside Tracker ($300/test, 2-4×/yr) — comprehensive bloodwork at home cadence. Attia-aligned panel.
5. CGM (Continuous Glucose Monitor — Stelo $89/mo, Lingo $89/mo, or Levels $300/mo) — only if metabolic dysregulation appears in bloodwork or if a 30-day pilot would teach Ben something about his diet’s glycemic response. Skip until bloodwork tells us we need it.
6. Cognitive baseline — annual NeuroTrack / Cambridge Brain Sciences / similar. Useful baseline for tracking 5-year drift.

Integrations we’d build for Claude Code visibility

• Whoop MCP — Whoop has a developer API. ~3-4 hours of work to wrap the daily-export endpoint. Output: daily JSON to vault, synthesis note weekly.
• Apple Health → vault — the iOS Claude connector does NOT propagate to Claude Code (separate processes, different OAuth flows). Two paths:
  • One-time: Health app → Profile → Export All Health Data → AirDrop the .zip to Mac → script to ingest. Annual refresh.
  • Ongoing: HealthAutoExport ($5 one-time iOS app) → automated CSV/JSON export to iCloud Drive → vault picks up. Recommended.
• Bloodwork OCR — when bloodwork PDFs come in, run an extraction skill that pulls the panel into structured form, files to 04-finance/health/ (sensitive subdir), updates a longitudinal view.
• Cronos: weekly health-pulse skill (analogous to /finance-pulse) that surfaces Whoop trend + sleep + recovery. Monthly DEXA-comparison. Quarterly bloodwork review.

Actions — the controllable inputs

Filed-today synthesis notes specify the protocol details. Top-of-file summary:

Sinclair — selectively useful for a 30-something healthy

See 2026-05-06-sinclair-longevity-protocol.md. Summary: 8 evidence-strong items, 8 contested. Sinclair has quietly walked back rapamycin + taurine in 2025; the metabolic-health-as-leading-indicator framing is the only durably valuable layer for a healthy 30-something. NMN/NR efficacy is contested. Don’t blindly copy his supplement stack.

Attia — the operating manual

See 2026-05-06-attia-longevity-framework.md. Summary: 5 immediately-actionable items for Ben right now.

1. Bloodwork ask — ApoB + Lp(a) at next physical (the two markers Attia says matter most for cardiovascular risk).
2. Zone 2 base — 4×45min/wk at HR ~ (180 - age) - 20. Indoor bike or jog. The single most evidence-strong cardio intervention.
3. VO2max session — 1×/wk 4×4min intervals at 90%+ max HR. The marginal-decade tail-fitness lever.
4. Strength — 3×/wk biased to rucks, stairs, weighted carries. The functional-capability axis.
5. Annual DEXA + ApoB recheck — close the feedback loop on body comp + cardio risk.

Where Attia and Sinclair disagree

• Supplements: Sinclair is supplement-heavy (NMN, resveratrol, etc.); Attia is conservative (“most supplements lack evidence at the doses people take them”).
• Rapamycin: Sinclair walked back; Attia uses it intermittently himself (controversial).
• NMN/NR: Attia is openly skeptical of bioavailability + efficacy.

Specific tactical answers for today

Skincare

OneSkin OS-01 peptide (Carolina Reis Oliveira, Moonshots EP #120, 2024-09-19). Senolytic peptide that reduces senescent cell load in skin by up to 40% (their published data). Strong R&D process — lab-grown human skin testing platform, progeria-cell screen, screened 900+ peptide candidates.

Verdict: worth trying, not snake oil. Differentiated from retinoids (which don’t target senescence) and rapamycin topicals (toxicity / dosing window concerns).

Bias to flag: Diamandis is an investor and advisor in OneSkin. The Moonshots episode reads more like a portfolio company spotlight than a neutral interview. Independent reviews on r/SkincareAddiction and Beautypedia are mixed-positive.

Cost: ~$120 / 50ml jar. Lasts ~3 months at daily use on face only.

Stack alongside: sunscreen daily (best-evidence anti-aging skin intervention by orders of magnitude — UV exposure is the single largest extrinsic-aging driver). Tretinoin nightly (prescription, evidence-strong for photoaging). OneSkin slots in alongside, not as a replacement.

Open questions for the founder

1. Outcome target candidate — A, B, or C? Default-recommendation is C (composite, quarterly rotation).
2. First-quarter focus — bloodwork baseline (recommended) vs Whoop wiring vs both in parallel (cost: ~3-4hr Whoop MCP work, lab requisition + visit).
3. Approach to rapamycin / NMN — Attia-conservative (skip until evidence improves) or Sinclair-curious (5mg rapa weekly + NMN)? Default: Attia-conservative.
4. Supplement stack starting point — broad or minimal? Recommended minimal: vitamin D3 (only if labs say deficient), creatine (5g/day, evidence-strong), magnesium glycinate (evening), omega-3 if dietary intake low. Everything else after bloodwork.

Cross-references

• ~/rdco-vault/01-projects/health-and-longevity/2026-05-06-sinclair-longevity-protocol.md
• ~/rdco-vault/01-projects/health-and-longevity/2026-05-06-attia-longevity-framework.md
• ~/rdco-vault/06-reference/2024-09-19-moonshots-ep120-carolina-oliveira-skin-aging.md (OneSkin)
• ~/rdco-vault/06-reference/2024-01-11-moonshots-ep80-mark-hyman-longevity.md
• ~/rdco-vault/06-reference/2024-07-25-moonshots-ep110-krystal-zell-muscle-longevity.md
• ~/rdco-vault/06-reference/2025-04-30-moonshots-ep167-sleep-science-body-brain.md
• ~/rdco-vault/06-reference/2025-05-01-moonshots-ep168-sleep-melatonin-sex.md
• ~/.claude/projects/-Users-ray/memory/feedback_targeting_system_prioritization_filter.md (the four-layer filter Ben’s instinctively applying)

Next agent actions (after founder responds to outcome-target question)

1. Build Whoop MCP wrapper (~4hr)
2. Add a /health-pulse skill (weekly cron, like /finance-pulse)
3. Help draft the bloodwork lab requisition (Attia panel) for Ben’s next physical
4. Build a HealthAutoExport ingest pipeline if he buys the iOS app
5. Stand up ~/rdco-vault/04-finance/health/ (sensitive subdir) for bloodwork PDFs + structured longitudinal data